Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer's Disease Treatment.
Line SéguyLéna GuyonManon MaurelPascal VerdiéAudrey DavisSophie CorvaisierVincent LisowskiPatrick DallemagneAnne-Claire GrooAurélie Malzert-FreonPublished in: Pharmaceutics (2021)
The developed peptide-22 functionalized Tg-NEs appear as a valuable tool to allow exploration of the repurposed tegaserod in AD treatment in further preclinical studies.
Keyphrases